Our study identifies PIKfyve as a critical regulator of OBI‐induced LMP and DCD, providing mechanistic insights into how lysosomal integrity governs B‐cell lymphoma sensitivity to anti‐CD20 therapy. The gene discussed is PIKFYVE; the disease is B-cell non-Hodgkin lymphoma.